Rutgers Cancer Institute of New Jersey
Christopher J. Molloy is currently serving as Associate Director of BioPharma Alliances in Oncology at Rutgers Cancer Institute of New Jersey. With a background in academia and industry, Christopher J. has held various leadership positions at Rutgers University, Johnson & Johnson, 3-Dimensional Pharmaceuticals, Inc., Bristol-Myers Squibb, and the National Cancer Institute. Molloy's responsibilities have included overseeing research, economic development, and academic integration in the biomedical and health sciences fields.
This person is not in any teams
Rutgers Cancer Institute of New Jersey
As one of the nation’s elite National Cancer Institute-designated Comprehensive Cancer Centers and the only one in New Jersey, Rutgers Cancer Institute of New Jersey delivers advanced comprehensive care to adults and children, and conducts cutting-edge cancer research. As part of Rutgers, The State University of New Jersey, Cancer Institute researchers and physicians transform discoveries into clinical practice and provide education and outreach regarding cancer prevention, detection and treatment.